๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

60 RISK FACTORS FOR RECURRENCE OF PRIMARY SCLEROSING CHOLANGITIS

โœ Scribed by E.B. Alabraba; P. Nightingale; B.K. Gunson; D.F. Mirza; J.M. Neuberger


Book ID
117375986
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
59 KB
Volume
48
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Risk factors for recurrence of primary s
โœ Evangelos Cholongitas; Vibhakorn Shusang; George V. Papatheodoridis; Laura Marel ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 94 KB ๐Ÿ‘ 2 views

Liver transplantation (LT) is the only therapeutic option for end-stage primary sclerosing cholangitis (PSC), but PSC can recur (rPSC) in some patients after LT. The aim of our study was to evaluate the risk factors associated with rPSC. Between 1989 and 2004, 69 patients receiving transplantation f

Risk factors for recurrence of primary s
โœ Jacob Alexander; James D. Lord; Matthew M. Yeh; Carlos Cuevas; Ramasamy Bakthava ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 123 KB ๐Ÿ‘ 2 views

Orthotopic liver transplantation (OLT) is the only effective treatment for end-stage liver disease due to primary sclerosing cholangitis (PSC). Recurrence of PSC has recently emerged as a leading cause of allograft failure in the long term. There is limited data on risk factors for recurrence of PSC

Risk factors in primary sclerosing chola
โœ Erik Schrumpf; Michel Abdelnoor; Olav Fausa; Kjell Elgjo; Eystein Jenssen; Finn ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 445 KB
A re-evaluation of the risk factors for
โœ Edward Alabraba; Peter Nightingale; Bridget Gunson; Stefan Hubscher; Simon Ollif ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 497 KB

Previously, we have found that the absence of the colon after liver transplantation (LT) protects the patient from recurrent primary sclerosing cholangitis (rPSC). As our previous observation has not been confirmed in other series, we have reviewed our cohort of patients grafted for primary sclerosi